SEELQ — Seelos Therapeutics Share News
0.000.00%
Last trade - 00:00HealthcareHighly SpeculativeMicro Cap
Brief: Seelos Therapeutics Announces Notice Of Delisting From Nasdaq And Transfer Of Listing To Over-The-Counter Market
Brief: Seelos Announces Postponement Of Its Annual Meeting Of Stockholders
Brief: Seelos Therapeutics Announces 1-For-16 Reverse Stock Split
U.S. STOCKS ON THE MOVE-Copper miners, Visa, Bluebird bio
Seelos Therapeutics surges on deal with U.S. Army to develop PTSD drug
U.S. STOCKS ON THE MOVE-Copper miners, Biogen, Salesforce
Seelos Therapeutics surges on deal with U.S. Army to develop PTSD drug
Brief: Seelos Therapeutics Announces The Signing Of A Material Transfer Agreement With U.S. Army Medical Materiel Development Activity (Usammda) To Evaluate Sls-002 For Treatment Of Ptsd
Brief: Seelos Therapeutics, On April 30, Announced A Reduction In Its Workforce That Affected About 33% Of Its Current Employees
Brief: Seelos Therapeutics Appoints Richard Pascoe Chairman Of Board
U.S. STOCKS ON THE MOVE-US energy sector, Avis, NuScale
U.S. STOCKS ON THE MOVE-National Cinemedia, Crinetics Pharma, Nordstrom
Seelos falls on failed ALS drug study
Seelos Therapeutics' ALS treatment fails in mid-stage study (updated)
Seelos says ALS treatment fails in mid-stage study
Brief: Seelos Therapeutics Provides Update On Top-Line Results From Its Amyotrophic Lateral Sclerosis Study With SLS-005 (IV Trehalose)
Brief: Seelos Therapeutics Inc Files For Common Stock Offering Of Up To 3.4 Million Shares By Selling Stockholders- SEC Filing
Brief: Seelos Therapeutics, Inc. Announces $4.0 Million Registered Direct Offering And Concurrent Private Placement Priced At-The-Market Under Nasdaq Rules
Brief: Seelos Therapeutics Inc says company Plans To Continue Its Previously Announced Potential Partnership Discussions